Pakhsh Razi Company
Pakhsh Razi Company
Pakhsh Razi Company is a listed pharmaceutical distribution company based in Tehran and active in the nationwide distribution of drugs and medical consumables. In the Hormuz Group company graph, it matters because pharmaceutical distributors form the operating bridge between producers, importers, hospitals, pharmacies, and patients. Its national distribution centers and listed status make it useful for mapping healthcare logistics, medicine availability, counterparty risk, and distributor economics.
Products & Services
Pakhsh Razi Company distributes pharmaceuticals, medical consumables, medical equipment, healthcare products, domestic and imported medicines, pharmacy products, hospital supplies, and related regulated healthcare goods through a nationwide distribution network. Its infrastructure includes a central warehouse, multiple distribution centers, transport fleet, supplier relationships, pharmacy and medical-center coverage, and shareholder-facing IFB disclosure.
Investment Relevance
Pakhsh Razi is relevant for investors assessing Iran's pharmaceutical logistics, medical-consumables distribution, pharmacy supply chains, healthcare receivables, working-capital pressure, and the performance of listed drug distributors. It can support analysis of drug availability, medical-equipment access, distribution margins, inventory management, supplier concentration, and the effect of inflation and regulated prices on healthcare supply chains. Due diligence should review updated Codal disclosures, IFB trading status, branch and warehouse network, transport fleet, supplier and customer concentration, cold-chain capacity, receivables aging, financing costs, regulatory compliance, product mix, medical-equipment exposure, and any share-trading halts or disclosure issues.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, pharmaceutical-distribution, medical-consumables, IFB/Codal disclosure, logistics, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence.